Cancer Therapy Vol 1, page 291 radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol 10, 348-54. Schaefer O, Lohrmann C, Herling M, et al (2002) Combined radiofrequency thermal ablation and percutaneous cementoplasty treatment of a pathologic fracture. J Vasc Interv Radiol 13, 1047-50. Schaefer O, Lohrmann C, Markmiller M, et al (2003) Technical innovation. Combined treatment of a spinal metastasis with radiofrequency heat ablation and vertebroplasty. Am J Roentgenol 180, 1075-7. Seidenfeld J, Korn A, Aronson N (2002) Radiofrequency ablation of unresectable liver metastases. J Am Coll Surg 195, 378-86. Seidenfeld J, Korn A, Aronson N (2002) Radiofrequency ablation of unresectable primary liver cancer. J Am Coll Surg 194, 813-28 discussion 828. Sharifi J, Khawli LA, Hornick JL, Epstein AL (1998) Improving monoclonal antibody pharmacokinetics via chemical modification. Q J Nucl Med 42, 242-9. Shibata T, Iimuro Y, Yamamoto Y, et al (2002) Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223, 331-7. Steinke K, Glenn D, King J, Morris DL (2003) Percutaneous pulmonary radiofrequency ablation: difficulty achieving complete ablations in big lung lesions. Br J Radiol 76, 7425. Steinke K, King J, Glenn D, Morris DL (2003) Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 27, 750-7. Virag J, Kadar E, Szentpetery F, Jakab F (1997) Experiences with ethanol infiltration of the liver metastases of colorectal tumors (preliminary study) . Acta Chir Hung 36, 386-8.
von Mehren M, Adams GP, Weiner LM (2003) Monoclonal antibody therapy for cancer. Annu Rev Med 54, 343-69. Weiner LM (1999) Monoclonal antibody therapy of cancer. Semin Oncol 26(5 Suppl 14) , 43-51. Wessels B, Jensen,R., Nelson,A., Shan,J., Chew,T (2001) Image fusion and patient specific dosimetry for tumor response and toxicity evaluation in patients with glioma undergoing radionuclide therapy. Neuro-Oncology 3, 353. Witzig TE, Gordon LI, Cabanillas F, et al (2002) Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol 20, 2453-63. Wood TF, Rose DM, Chung M, et al (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7, 593-600.
Dr. Peter M. Anderson
291